Search filters

List of works by Cheolwon Suh

(18)F-FDG PET in Patients with Primary Systemic Anaplastic Large Cell Lymphoma: Differential Features According to Expression of Anaplastic Lymphoma Kinase

scientific article

18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement

scientific article published on 6 November 2015

A Case of CD4+T-Cell Large Granular Lymphocytic Leukemia ⬇️

scientific article published on April 17, 2013

A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer

scientific article published on 01 February 2003

A case of ALK negative anaplastic large cell lymphoma with leukaemic manifestation, transformed from CD4 positive T-cell large granular lymphocytic leukaemia

scientific article published in January 2015

A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy

scientific article published on 16 June 2009

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma

scientific article

A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma

scientific article

A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy

scientific article

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma

scientific article

A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer

scientific article

A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas

scientific article

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas ⬇️

scientific article published on March 28, 2012

A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma

scientific article published on 02 January 2020

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of th

scientific article published on 24 April 2020

A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial

scientific article

A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)

A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels

scientific article published on 20 November 2020

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

scientific article

A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection

scientific article published in January 2007

A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience

scientific article published on 5 August 2012

Abbreviated chemotherapy for limited-stage diffuse large B-cell lymphoma after complete resection

scientific article published on 25 June 2014

Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages

scientific article

Active immunization using dendritic cells mixed with tumor cells inhibits the growth of lymphomas

scientific article

Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma ⬇️

scientific article published on June 21, 2011

Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience.

scientific article published on 24 March 2014

Angiosarcoma of the retroperitoneum: report on a patient treated with sunitinib.

scientific article published on 20 May 2009

Angiosarcomas of the Bilateral Breast and Heart: Which One is the Primary Site? ⬇️

scientific article published on May 31, 2012

Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party

scientific article

Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients

scientific article published on 07 January 2021

Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study

scientific article

Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement

scientific article published on December 2008

Autophagic Markers BECLIN 1 and LC3 are Associated with Prognosis of Multiple Myeloma

scientific article published on 3 April 2015

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity

scientific article published on 21 August 2007

BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: A single center comparative analysis of efficacy and toxicity ⬇️

scientific article published on August 3, 2010

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party

scientific article published on 23 September 2016

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis

scientific article published on 4 April 2018

Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma

scientific article published on 20 December 2019

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.

scientific article

Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified

scientific article published on 15 July 2015

Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma

scientific article published in March 2018

Bone marrow findings of 23 Korean post‐transplant lymphoproliferative disorder patients: a single‐center experience ⬇️

scientific article published on June 13, 2012

Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma

scientific article

Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial ⬇️

scientific article published on July 4, 2012

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

scientific article

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean

scientific article published on 10 December 2009

Both-sided intra-atrial intracardiac metastases as the initial presentation of testicular seminoma

scientific article published on 24 June 2007

Breast implant-associated anaplastic large cell lymphoma: the first South Korean case

scientific article published on 18 August 2020

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

scientific article published on 01 January 2019

CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma

scientific article published on 29 January 2014

CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma ⬇️

scientific article published on November 24, 2011

CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma

scientific article published in April 2014

Case series of precursor B-cell lymphoblastic lymphoma

scientific article

Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter study

scientific article

Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea ⬇️

scientific article published on 06 July 2013

Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study

scientific article

Clinical Features and Survival of Patients With Follicular Lymphoma in Korea

scientific article

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.

scientific article published on 08 May 2015

Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma

scientific article published in January 2008

Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy

scientific article published on 8 December 2017

Clinical characteristics and outcomes of primary bone lymphoma in Korea ⬇️

scientific article published on September 25, 2012

Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders

scientific article

Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients

scientific article

Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience

scientific article published on 23 December 2014

Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)

scientific article published on 26 July 2011

Clinical features and prognostic model for extranasal NK/T‐cell lymphoma ⬇️

scientific article published on August 1, 2012

Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report

scientific article published on 5 March 2010

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)

scientific article published on 20 October 2020

Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry

scientific article

Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry

scientific article

Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience

scholarly article by Jihoon Kang et al published September 2018 in Blood research

Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma

scientific article published on 24 March 2014

Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea.

scientific article published in July 2009

Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma

scientific article published in April 2007

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

scientific article published on 18 December 2019

Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of

scientific article published on 20 August 2014

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

scientific article

Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement

scientific article published on 03 October 2013

Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma

scientific article published on 03 September 2013

Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest

scientific article

Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia

scientific article published on 01 May 2020

Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience

scientific article published on 08 June 2009

Clinicopathological and prognostic significance of BCL2, BCL6, MYC, and IRF4 copy number gains and translocations in follicular lymphoma: a study by FISH analysis

scientific article published on 13 September 2020

Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified

scientific article published on 01 March 2019

Collection of peripheral blood progenitor cells: analysis of factors predicting the yields

scientific article published in August 2003

Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial

scientific article published on 01 December 2002

Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma

scientific article published on August 2006

Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone

scientific article

Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).

scientific article published on 11 April 2017

Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.

scientific article published in April 2009

Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy.

scientific article published on 22 August 2017

Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.

scientific article published on 20 June 2014

Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets

scientific article published on 19 August 2010

Consideration of aggressive therapeutic strategies for primary testicular lymphoma

scientific article

Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities

scientific article published on 10 February 2014

Development of subsequent bloodstream infection in patients with positive Hickman catheter blood cultures and negative peripheral blood cultures

scientific article published on 12 March 2011

Diagnostic sensitivity of a panel of tests to detect monoclonal protein in Korean multiple myeloma patients

scientific article published in August 2013

Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities

scientific article published on 10 December 2019

Diffuse Large B-Cell Lymphoma with Involvement of the Breast and Testis in a Male Patient.

scientific article published on 11 September 2014

Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP

scientific article published on 06 January 2020

Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.

scientific article

Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity ⬇️

scientific article published on August 24, 2010

Double autologous stem cell transplantation for multiple myeloma: a Korean single center study

scientific article published on September 2005

EBV-positive diffuse large B-cell lymphoma of the elderly with aberrant expression of CD3 and TIA-1

scientific article published on 25 June 2013

ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience

scientific article

Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation.

scientific article published on 8 January 2013

Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type

scientific article published on June 2007

Efficacy and Survival Outcome Associated with the Use of Novel Agents and Autologous Stem Cell Transplantation in Cases of Immunoglobulin D Multiple Myeloma in Korea

scientific article published on 10 April 2018

Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial

scientific article published on 13 August 2019

Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma

article published in 2019

Electrophysiologic features of POEMS syndrome compared with MGUS-related neuropathy.

scientific article

Endoscopic and clinical analysis of primary T-cell lymphoma of the gastrointestinal tract according to pathological subtype

scientific article published on May 2014

Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma

scientific article

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

scientific article published on 20 January 2009

Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.

scientific article

Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma

scientific article published on March 2008

Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study

scientific article published on 01 October 2011

Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update

scientific article

Expression of CD99 in Multiple Myeloma: A Clinicopathologic and Immunohistochemical Study of 170 Cases

scientific article

Expression of JL1 in Burkitt lymphoma is associated with improved overall survival

scientific article published on 4 August 2011

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence

scientific article published on 29 January 2008

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

scientific article

Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.

scientific article

FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy

scientific article published on 14 June 2011

False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccination

scientific article published on June 2011

Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetan

scientific article published on 21 May 2010

Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09).

scientific article published on 05 January 2017

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

scientific article published on 06 August 2020

First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung

scientific article published on 27 February 2012

GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression

scientific article published on 21 February 2017

Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study

scientific article published on 07 August 2020

Growth Suppression and Induction of Chemosensitivity in Human Gallbladder Epithelial Carcinoma Cells (GBCE) by Adenovirus-Mediated Transfer of the Wild-type p53 Gene

scientific article

Health-related quality of life in Korean lymphoma survivors compared with the general population

scientific article published on 20 June 2014

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group

scientific article published on August 2013

High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified

scientific article published in August 2014

High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study

scientific article

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

scientific article published on 26 January 2007

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma ⬇️

scientific article published on January 26, 2013

High-dose chemotherapy of cyclophosphamide, thiotepa and carboplatin (CTCb) followed by autologous stem-cell transplantation as a consolidation for breast cancer patients with 10 or more positive lymph nodes: a 5-year follow-up results

scientific article published on 30 June 2005

High-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result

scientific article published on 28 February 2005

High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the

scientific article published on 17 October 2013

Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma

scientific article

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study

scientific article published on 04 October 2016

Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma

scientific article published on 01 May 2021

Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm ⬇️

scientific article published on March 7, 2013

Immunophenotypic Characterization and Quantification of Neoplastic Bone Marrow Plasma Cells by Multiparametric Flow Cytometry and Its Clinical Significance in Korean Myeloma Patients ⬇️

scientific article published on March 27, 2013

Impact of the Epstein–Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea ⬇️

scientific article published on April 18, 2012

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma

scientific article published on 18 September 2017

Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma

scientific article published on 8 December 2017

Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myeloma ⬇️

scientific article published on April 25, 2012

Infarction and Perforation of the Small Intestine due to Tumor Emboli from Disseminated Rectal Cancer

scientific article published on 30 September 2008

Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma

scientific article

Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000

scientific article published on 01 December 2004

Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression

scientific article

Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine

scientific article

Intestinal diffuse large B-cell lymphoma: an evaluation of different staging systems

scientific article published on 26 December 2013

Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study.

scientific article published on 21 December 2015

Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.

scientific article

Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.

scientific article published on 26 July 2015

JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma

scientific article published on 01 January 2020

Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.

scientific article published on 6 May 2010

Korean translation and validation of the functional assessment of cancer therapy-lung (FACT-L) version 4.

scientific article published in February 2006

LGALS3 as a prognostic factor for classical Hodgkin's lymphoma

scientific article published on 07 March 2014

Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.

scientific article published on 12 September 2013

Leptomeningeal carcinomatosis in gastric cancer

scientific article

Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP ⬇️

scientific article published on December 22, 2010

Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)

scientific article published on 28 September 2020

Low-dose lenograstim to enhance engraftment after autologous stem cell transplantation: a prospective randomized evaluation of two different fixed doses

scientific article published in April 2004

Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma ⬇️

scientific article published on December 28, 2011

Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial

scientific article published on 22 January 2018

MET and MST1R as prognostic factors for classical Hodgkin's lymphoma ⬇️

scientific article published on April 5, 2013

Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy ⬇️

scientific article published on August 30, 2011

Mediastinal single nodal relapse of a nasal NK/T cell lymphoma

scientific article published in September 2007

Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate

scientific article published on 25 October 2016

Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma ⬇️

scientific article published on August 31, 2010

Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.

scientific article published in March 2010

Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma ⬇️

scientific article published on May 6, 2013

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer

scientific article

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) ⬇️

scientific article published on July 29, 2011

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma

scientific article published on 06 September 2019

Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study ⬇️

scientific article published on September 14, 2010

Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.

scientific article published on 11 June 2010

Murine bone marrow stromal cells: implications for their use in gene modified cell therapy

scientific article published on November 2003

Myelomatous Pleural Effusion: A Case Series in a Single Institution and Literature Review ⬇️

scientific article published on October 3, 2011

Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction

scientific article

New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy

scientific article published in August 2006

Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors

scientific article

Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma

scientific article published on 12 March 2016

Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma

scientific article published on 04 December 2020

Organ-specific considerations for marginal zone lymphomas in Korea, based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies

scholarly article by Sung Yong Oh & Cheolwon Suh published March 2019 in Blood research

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial

scientific article published in August 2003

Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia

scientific article published on 24 June 2010

Outcomes and prognostic factors of patients with lung cancer and pneumonia-induced respiratory failure in a medical intensive care unit: a single-center study

scientific article published on 13 January 2014

PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma

scientific article published on 25 August 2017

Peritoneal dissemination from malignant fibrous histiocytoma of the buttock: unusual metastases from a rare tumor

scientific article published on 31 December 2008

Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis

scientific article published on 29 March 2019

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.

scientific article published on 9 March 2018

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer ⬇️

scientific article published on January 1, 2002

Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

scientific article published on 27 December 2011

Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study

scientific article published on 16 October 2019

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

scientific article published on 11 October 2011

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets.

scientific article published on 25 February 2010

Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial.

scientific article published on 7 May 2009

Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients ⬇️

scientific article published on April 16, 2011

Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer

scientific article

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer

scientific article published on 01 July 2003

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)

scientific article published on 16 August 2016

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

scientific article

Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

scientific article

Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer

scientific article published on 01 November 2007

Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma

scientific article

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for I

scientific article published on 25 September 2017

Plerixafor use for peripheral blood stem cell mobilization in Korea

scientific article published on June 2013

Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy

scientific article published on 7 October 2016

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy

scientific article published on 10 October 2012

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

scientific article published on 09 January 2020

Poor outcomes for IgD multiple myeloma patients following high-dose melphalan and autologous stem cell transplantation: a single center experience

scientific article published on October 2008

Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009

article

Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).

scientific article published in July 2002

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

scientific article published on 30 December 2019

Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma

scientific article

Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology

scientific article published on 26 December 2017

Primary histiocytic sarcoma of the central nervous system

scientific article published on 29 August 2014

Primary mediastinal large B-cell lymphoma: a single-center experience in Korea

scientific article published on 24 March 2014

Primary non-Hodgkin's lymphomas of the major salivary glands

scientific article published in January 2008

Primary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical Center

scientific article

Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma study

scientific article published on 15 December 2011

Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study

scientific article published on 15 September 2020

Prognostic Significance of COX-2 Expression and Correlation With Bcl-2 and VEGF Expression, Microvessel Density, and Clinical Variables in Classical Hodgkin Lymphoma ⬇️

scientific article published on August 1, 2013

Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.

scientific article published on 23 April 2015

Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin Lymphoma ⬇️

scientific article published on December 1, 2012

Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels

scientific article published on 17 December 2020

Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients

scientific article published on 4 February 2015

Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean mul

scientific article published on 11 January 2016

Prognostic factors in non-Hodgkin's lymphoma patients treated by autologous stem cell transplantation: a single center experience

scientific article published on 31 October 2005

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) ⬇️

scientific article published on August 13, 2012

Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma

scientific article published on 19 January 2014

Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP ⬇️

scientific article published on May 1, 2013

Prognostic impact of germinal center B-cell-like and non-germinal center B-cell-like subtypes of bone marrow involvement in patients with diffuse large B-cell lymphoma treated with R-CHOP

scientific article published on 01 November 2018

Prognostic impact of β₂-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma

scientific article published on 17 July 2014

Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma ⬇️

scientific article published on January 29, 2013

Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma

scientific article published on 24 December 2013

Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma

scientific article

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era

scientific article published on 18 October 2016

Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma

scientific article published on 24 December 2013

Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy.

scientific article published on 29 November 2011

Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck

scientific article

Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma

scientific article published on 17 December 2015

Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma

scientific article published on 10 January 2008

Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin's lymphoma

scientific article

Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study

scientific article published on 19 December 2009

Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2

scientific article published on 30 June 2020

RGS1 expression is associated with poor prognosis in multiple myeloma

scientific article published on 21 July 2016

Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the International Radioimmunotherapy Network

scientific article published on 9 August 2011

Radioimmunotherapy for Mantle Cell Lymphoma: 5-Year Follow-up of 90 Patients from the International RIT-Registry

Radioimmunotherapy with 131I‐rituximab for patients with relapsed/refractory B‐cell non‐Hodgkin's lymphoma (NHL) ⬇️

scientific article published on June 1, 2011

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

scientific article

Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy

scientific article

Receptor tyrosine kinases MET and RON as prognostic factors in diffuse large B‐cell lymphoma patients receiving R‐CHOP ⬇️

scientific article published on July 11, 2013

Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience.

scientific article

Relapse pattern and prognostic factors for patients with primary CNS lymphoma

scientific article published on 26 June 2012

Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma ⬇️

scientific article published on March 28, 2012

Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases

scientific article

Relative Frequency, Clinical Features, and Survival Outcomes of 395 Patients with Cutaneous Lymphoma in Korea: A Subgroup Analysis per 10-year Period

scientific article published on 15 March 2016

Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era.

scientific article published on 26 December 2017

Remobilization of hematopoietic stem cells with high‐dose methotrexate and cytarabine in patients with non‐Hodgkin's lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines ⬇️

scientific article published on June 26, 2013

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma ⬇️

scientific article published on January 31, 2013

Report of AIDS-related lymphoma in South Korea

article

Results of Intercontinental Cooperative Non-Hodgkin T-Cell Lymphoma Prospective Registry Study

Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working Party

scientific article

Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.

scientific article published in August 2007

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

scientific article published on 10 November 2019

Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial

scientific article

Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial

scientific article

Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type

scientific article published on 27 May 2015

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma ⬇️

scientific article published on October 20, 2010

Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.

scientific article published on October 2015

Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis

scientific article published on 25 September 2017

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly dia

scientific article published on July 26, 2011

Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma

scientific article published on 21 October 2009

Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma

scientific article published on 16 February 2015

Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor

scientific article

Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?

scientific article

Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells ⬇️

scientific article published on December 24, 2012

Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer

scientific article published on 15 August 2014

Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

scientific article published on 01 November 2010

Subtle CD20 positivity in the bone marrow of a patient who has a mucosa‐associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow ⬇️

scientific article published on November 16, 2012

Successful rapid drug desensitization to methotrexate in a patient with primary central nervous system lymphoma

scientific article published on 27 March 2018

Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis

scientific article published on 21 May 2019

TCL1 expression predicts overall survival in patients with mantle cell lymphoma.

scientific article published on 17 February 2015

The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective

scientific article published on 27 March 2017

The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages ⬇️

scientific article published on May 15, 2012

The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age

scientific article published on 16 September 2014

The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms

scientific article published on 01 August 2018

The clinical outcomes of rituximab biosimilar CT-P10 (Truxima®) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience

scientific article published on 15 April 2020

The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma ⬇️

scientific article published on 03 July 2012

The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma

scientific article published in October 2003

The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.

scientific article published on 22 July 2017

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy

scientific article

The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin’s lymphoma patients ⬇️

scientific article published on May 21, 2013

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160).

scientific article published on 16 June 2017

The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study

scientific article published on 3 July 2012

The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2

scientific article published on May 1, 2012

Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma

scientific article published on 15 April 2019

Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study

scientific article published on 11 June 2018

Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis.

scientific article

Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience

scientific article published on 25 September 2014

Treatment outcome of nasal natural killer/T-cell lymphoma ⬇️

scientific article published on September 30, 2011

Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma

scientific article

Treatment with Intravenous Busulfan, Melphalan, and Etoposide (BuME) followed by Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from the Consortium for Improving Survival of Lymphoma (CISL)

scientific article published on 01 June 2020

VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma ⬇️

scientific article published on January 9, 2012

Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

scientific article published on 05 October 2018

Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL).

scientific article

Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer

scientific article published on 01 August 2003

Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

scientific article published on 21 November 2014

Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma ⬇️

scientific article published on June 26, 2012

Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

scientific article published on 23 June 2009

[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung

scientific article

Paulina is supported by:

About Paulina

Help